Navigation Links
NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Date:9/21/2007

SAN CARLOS, Calif., Sept. 21 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that it has completed enrollment in study C119, a second Phase 3 clinical trial of its lead product candidate NGX-4010 for the treatment of painful HIV-distal sensory polyneuropathy (HIV-DSP). NGX-4010 is a dermal patch designed to manage peripheral neuropathic pain. Previously completed Phase 3 trials demonstrated that a single, 30- or 60-minute treatment with NGX-4010 applied directly to the site of pain may provide pain relief for up to three months. C119 is a randomized, double-blind, controlled study that has enrolled over 480 patients at study sites in the United States, the United Kingdom, Australia and Canada.

"We believe that completion of enrollment in our C119 study marks a significant milestone in our NGX-4010 development program in HIV-DSP. We are currently in the follow-up phase of the study and expect to be able to provide top-line results near the end of the first quarter of 2008," commented Dr. Jeffery Tobias, Chief Medical Officer. "HIV-DSP is an important and underserved problem in patients with HIV/AIDS. There are currently no approved therapies for this indication. With the completion of enrollment in study C119, we are moving closer to our goal of providing an effective treatment for this patient population."

The study protocol for study C119 evaluates the effect of a single, 30- or 60-minute treatment with NGX-4010 or a low-concentration control patch applied directly to the patient's site of pain. NGX-4010 is administered by a physician during an in-office procedure. After 30 or 60 minutes, the study patch is removed and the patient's response to treatment is evaluated during the su
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
8. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014   Ventana Medical Systems, ... today announced that its VENTANA System for Primary ... the European Union for routine pathology, including primary ... of VENTANA Virtuoso software coupled with either the ... slide scanner, provides automated digital slide creation, case ...
(Date:8/20/2014)... -- Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, ... FDA (CFDA) approval and has subsequently launched its ... China domestic market.  Under the ... Sinochem Jiangsu Pharmaceutical Co., Ltd., Amerigen is manufacturing ... China CFDA certified oral solid dose facility in ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
... at the , 2007 American Society of Clinical ... Patients with AML and in,Refractory , ALL Patients ... Aloxi(R),with , the 5-HT3 Receptor Reported-- , --Results ... with Multimodal Therapy, including Gliadel(R) Described-- , --Survival ...
... June 05, 2007 /PRNewswire-USNewswire/ -- The Barbara,Ann Karmanos ... of medicine and oncology, presented the outcome,of one ... clinical,trials in North America and chaired an education ... the American Society of,Clinical Oncology (ASCO) annual meeting ...
Cached Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3
(Date:8/20/2014)... both breast cancer relapses and responses to chemotherapy, ... newly found marker could help doctors classify each ... that is more effective. The discovery was a ... Molecular and Cell Biology (IMCB), and the Cancer ... National University of Singapore (NUS). , Despite advancements ...
(Date:8/20/2014)... Mass., (PRWEB) August 20, 2014 ... new report, PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES ... and detectors market is expected to grow to ... annual growth rate (CAGR) of 15.9%. Increasing ... region. , With a rapidly expanding range of ...
(Date:8/20/2014)... August 20, 2014 The finalists are ... leading health-marketing industry trade magazine, will honor the pharmaceutical ... Awards are given to outstanding companies, marketers and brand ... , “We are proud to announce that we ... entries with double the number of submissions we received ...
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 Little ... product—the Really Little Green Pouch —to meet growing ... feed babies and toddlers homemade foods. , “The ... Green Pouch co-founder Maggie Crawford. She continues, “Parents ... to limit exposure to things like pesticides and hidden ...
(Date:8/20/2014)... One Call Alert expands its line of ... a fully-mobile wearable device that connects customers to the help ... hours a day, 365 days a year. , ResCube can ... It operates on the T-Mobile nationwide network like a cell ... work. , Like with the other One Call Alert systems, ...
Breaking Medicine News(10 mins):Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:Little Green Pouch Launches New Product to Help Health-conscious Parents Reduce Babies’ Eco-footprint 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3
... Centers, Inc.,("GNC" the "Company" or "we"), the largest ... financial results for the third,quarter ended September 30, ... owned subsidiary of GNC Parent LLC,which was acquired ... Teachers, Pension Plan Board ("Teachers") through a merger ...
... RealAge features sneak peek and tips from YOU Docs, ... favorite doctors Mehmet,Oz, MD, and Michael Roizen, MD, first ... New York Times #1 best-seller in 2005. Now,these same ... YOU book series -- want to know, "What stands ...
... Holiday Gifts by November 20th to Support Free Delivery for ... Christmas, Express Option Also Available, ... ) a leading online retailer of health, beauty, vision, and,pharmacy ... troops at APO/FPO addresses around the world to take,advantage of ...
... Planning Guide for Los Angeles, SEATTLE, Nov. 11 ... guides to help them explore ideas and connect with,local ... a funeral,have none -- until now. The new LAFuneralGuide.com ... Angeles., "We want to help people consider all ...
... Winthrop-University Hospital celebrated its move to a new home. ... families gathered to form a "Life Line," or bridge, ... to the new Center at 120 Mineola Boulevard, suite ... was passed from person to person signifying the transfer ...
... Expanding for Plaintiffs with In Utero Injuries, is now available free from ... office is posting legal articles on their website in an effort to ... link to the full article. , ... Chicago, IL (PRWEB) November 11, ...
Cached Medicine News:Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 2Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 3Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 4Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 5Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 6Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 7Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 8Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 9Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 10Health News:Doctors Reveal Biology of Beauty in New Book 2Health News:drugstore.com Offers Free Shipping to U.S. Troops Serving Overseas and in the United States 2Health News:drugstore.com Offers Free Shipping to U.S. Troops Serving Overseas and in the United States 3Health News:Horse Drawn Hearse and Ash Scattering by Balloon - Hello LAFuneralGuide.com! 2Health News:Horse Drawn Hearse and Ash Scattering by Balloon - Hello LAFuneralGuide.com! 3Health News:Over 200 Patients and Families Create a Human Chain to Open A New Home for the Winthrop-University Hospital Cancer Center for Kids 2Health News:Free Article Now Available: 'Rights Expanding for Plaintiffs with In Utero Injuries' 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: